Inventor · disambiguated record
Dan Stoicescu
Also filed as: STOICESCU DAN · STOICESCU DAN FLORIN
5 granted patents·7 pending applications·8 citations·filing 2006–2022
71Inventor score
Top patents by PatentIndex Score
12 records- 0176US7718660B2Inhibitors of folic acid-dependent enzymesSTOICESCU DAN·Filed 2006·Granted May 18, 2010·4 cites·20 claims
- 0273US12264142B2Heterocyclic compoundsFloratek Pharma SA·Filed 2020·Granted Apr 1, 2025·1 cites·7 claims
- 0371US7875716B2Inhibitors of folic acid-dependent enzymesSTOICESCU DAN·Filed 2008·Granted Jan 25, 2011·2 cites·14 claims
- 0465US8247422B2Use of condensed pyrimidine derivatives for the treatment of rheumatoid arthritisSTOICESCU DAN·Filed 2008·Granted Aug 21, 2012·1 cites·15 claims
- 0564US2024209011A1Heteroaromatic phosphonium salts for treating cancerFLORATEK PHARMA S A·Filed 2022·Application pending·0 cites
- 0664US2024124503A1Heteroaromatic phosphonium salts and their use treating cancerFLORATEK PHARMA S A·Filed 2022·Application pending·0 cites
- 0764US2024101585A1Heteroaromatic phosphonium salts and their use treating cancerFLORATEK PHARMA AG·Filed 2022·Application pending·0 cites
- 0860US2024051930A1Heteroaromatic spermidine analogues and their anticancer activityFLORATEK PHARMA S A·Filed 2022·Application pending·0 cites
- 0960US2024132461A1Flavone deaza spermidine analogues and their use treating cancerFLORATEK PHARMA S A·Filed 2022·Application pending·0 cites
- 1053US2024239762A1Novel heterocyclic compoundsFLORATEK PHARMA S A·Filed 2022·Application pending·0 cites
- 1146US8518954B2Inhibitors of folic acid-dependent enzymesSTOICESCU DAN·Filed 2010·Granted Aug 27, 2013·0 cites·15 claims
- 1244US2022411448A1Chromene-4-one derivatives as brain-derived neurotrophic factor (bdnf) mimeticsFLORATEK PHARMA AG·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dan Stoicescu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →